Proshares Trust ZBIO
ZBIO
$28.46 +0.52 (+1.86%)
As of: Oct 2, 2026 · 12:55 PM EDT

Zenas BioPharma (ZBIO) Interest Coverage Ratio (2026)

Updated

Zenas BioPharma's (ZBIO) Interest Coverage Ratio was -62.59 for Q2 2026.

Analysis

Zenas BioPharma (ZBIO) Interest Coverage Ratio (2026) Analysis & Trends

For FY2025, Interest Coverage Ratio at Zenas BioPharma was -52.28.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Interest Cover (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 25.41
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn -
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn -
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn 10.28
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn 7.27
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 5.22
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn -42.08
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn -
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn -
10 Zenas BioPharma 1.71 Bn 1.71 Bn - -62.59
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -62.59
Mar 31, 2026 -210.19
API Access

Zenas BioPharma Interest Coverage Ratio API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=interest-coverage-ratio&ticker=ZBIO&period=max&api_key=YOUR_API_KEY